Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
- Status
- UNKNOWN
- Phase
- N/A
Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells
- Status
- COMPLETED
- Phase
- PHASE3
Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women
- Status
- COMPLETED
- Phase
- N/A
The Second Multicenter Hemophilia Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
- Status
- COMPLETED
- Phase
- PHASE2
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplantation for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study of TPI 287 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL)
- Status
- TERMINATED
- Phase
- PHASE2